October 14, 2017
Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel
Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…
Read More October 19, 2016
Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy
Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…
Read More June 9, 2015
Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting
Large Study Confirms the Benefit to Patients of Advanced Dosing Method for Saladax Biomedical, Inc.…
Read More